Cargando…

Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors

Heat shock protein 90 (Hsp90) is a chaperone responsible for the maturation of many cancer-related proteins, and is therefore an important target for the design of new anticancer agents. Several Hsp90 N-terminal domain inhibitors have been evaluated in clinical trials, but none have been approved as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dernovšek, Jaka, Zajec, Živa, Durcik, Martina, Mašič, Lucija Peterlin, Gobec, Martina, Zidar, Nace, Tomašič, Tihomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400049/ https://www.ncbi.nlm.nih.gov/pubmed/34452244 http://dx.doi.org/10.3390/pharmaceutics13081283

Ejemplares similares

In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors
por: Zajec, Živa, et al.
Publicado: (2022)

Discovery of Novel Hsp90 C-Terminal Inhibitors Using 3D-Pharmacophores Derived from Molecular Dynamics Simulations
por: Tomašič, Tihomir, et al.
Publicado: (2020)

Efficient Synthesis of Hydroxy-Substituted 2-Aminobenzo[d]thiazole-6-carboxylic Acid Derivatives as New Building Blocks in Drug Discovery
por: Durcik, Martina, et al.
Publicado: (2020)

Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation
por: Durcik, Martina, et al.
Publicado: (2020)

Exploring the Chemical Space of Benzothiazole-Based DNA Gyrase B Inhibitors
por: Skok, Žiga, et al.
Publicado: (2020)

Catalytic Stereoconvergent Synthesis of Homochiral β-CF(3), β-SCF(3), and β-OCF(3) Benzylic Alcohols
por: Cotman, Andrej Emanuel, et al.
Publicado: (2022)

Practical Synthesis and Application of Halogen-Doped Pyrrole Building Blocks
por: Cotman, Andrej Emanuel, et al.
Publicado: (2021)

Exploring the 5-Substituted 2-Aminobenzothiazole-Based DNA Gyrase B Inhibitors Active against ESKAPE Pathogens
por: Sterle, Maša, et al.
Publicado: (2023)

New Diarylamine K(V)10.1 Inhibitors and Their Anticancer Potential
por: Gubič, Špela, et al.
Publicado: (2022)

Rational design of balanced dual-targeting antibiotics with limited resistance
por: Nyerges, Akos, et al.
Publicado: (2020)

Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K(V)10.1 Pore Blockers
por: Toplak, Žan, et al.
Publicado: (2021)

Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa
por: Cotman, Andrej Emanuel, et al.
Publicado: (2023)

Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modeling
por: Gramec Skledar, Darja, et al.
Publicado: (2018)

Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors
por: van Klaveren, Sjors, et al.
Publicado: (2022)

Antimicrobial Activity of the Marine Alkaloids, Clathrodin and Oroidin, and Their Synthetic Analogues
por: Zidar, Nace, et al.
Publicado: (2014)

HSP90 Interacts with the Fibronectin N-terminal Domains and Increases Matrix Formation
por: Chakraborty, Abir, et al.
Publicado: (2020)

Intracellular Hydrolysis of Small-Molecule O-Linked N-Acetylglucosamine Transferase Inhibitors Differs among Cells and Is Not Required for Its Inhibition
por: Loi, Elena Maria, et al.
Publicado: (2020)

A Dynamic View of ATP-coupled Functioning Cycle of Hsp90 N-terminal Domain
por: Zhang, Huaqun, et al.
Publicado: (2015)

Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain
por: Terracciano, Stefania, et al.
Publicado: (2018)

New Quinolinone O-GlcNAc Transferase Inhibitors Based on Fragment Growth
por: Weiss, Matjaž, et al.
Publicado: (2021)

Resolving Hot Spots in the C-Terminal Dimerization Domain that Determine the Stability of the Molecular Chaperone Hsp90
por: Ciglia, Emanuele, et al.
Publicado: (2014)

C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis
por: Brown, Mark A., et al.
Publicado: (2015)

Modulation of Human Hsp90α Conformational Dynamics by Allosteric Ligand Interaction at the C-Terminal Domain
por: Penkler, David L., et al.
Publicado: (2019)

Efficient Synthesis and Docking Studies of Novel Benzothiazole-Based Pyrimidinesulfonamide Scaffolds as New Antiviral Agents and Hsp90α Inhibitors
por: Azzam, Rasha A., et al.
Publicado: (2020)

3D Pharmacophore-Based Discovery of Novel K(V)10.1 Inhibitors with Antiproliferative Activity
por: Toplak, Žan, et al.
Publicado: (2021)

The Adaptive Potential of the Middle Domain of Yeast Hsp90
por: Cote-Hammarlof, Pamela A, et al.
Publicado: (2020)

The activity of protein phosphatase 5 towards native clients is modulated by the middle- and C-terminal domains of Hsp90
por: Haslbeck, Veronika, et al.
Publicado: (2015)

Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain
por: Kim, Hyun-Hwi, et al.
Publicado: (2018)

Production and purification of human Hsp90β in Escherichia coli
por: Radli, Martina, et al.
Publicado: (2017)

SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90
por: Lian, Bin, et al.
Publicado: (2021)

Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90)
por: Mak, Oi Wei, et al.
Publicado: (2019)

Hsp90 C-Terminal Inhibitors Exhibit Antimigratory Activity by Disrupting the Hsp90α/Aha1 Complex in PC3-MM2 Cells
por: Ghosh, Suman, et al.
Publicado: (2014)

Mutations in the Hsp90 N Domain Identify a Site that Controls Dimer Opening and Expand Human Hsp90α Function in Yeast
por: Reidy, Michael, et al.
Publicado: (2020)

A Primate Specific Extra Domain in the Molecular Chaperone Hsp90
por: Tripathi, Vishwadeepak, et al.
Publicado: (2013)

Design of New Potent and Selective Thiophene-Based K(V)1.3 Inhibitors and Their Potential for Anticancer Activity
por: Gubič, Špela, et al.
Publicado: (2022)

Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K(V)1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers 2022, 14, 2595
por: Gubič, Špela, et al.
Publicado: (2023)

Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain
por: Hassan, Mujtaba, et al.
Publicado: (2021)

Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor
por: Khandelwal, Anuj, et al.
Publicado: (2018)

A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer
por: Park, Jung Min, et al.
Publicado: (2020)

Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening
por: Loi, Elena M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2gkufb9oo2chtk4gbkgbhv02jm